)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Metagenomi Therapeutics
Metagenomi Therapeutics (MGX) investor relations material
Metagenomi Therapeutics Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary5 Mar, 2026
Executive summary
Advanced core genome-editing technologies and sharpened strategic focus, highlighted by a corporate rebranding to reflect a clearer mission and identity.
Achieved significant progress in pipeline and collaborations, reinforcing technology versatility and differentiation.
Financial highlights
Cash, cash equivalents, and marketable securities totaled $160.8 million as of December 31, 2025, supporting operations through 4Q 2027.
Research and development expenses were $94.4 million for 2025, down from $109.2 million in 2024.
General and administrative expenses were $26.8 million for 2025, down from $32.0 million in 2024.
Collaboration revenue was $25.2 million in 2025, compared to $52.3 million in 2024.
Net loss for 2025 was $87.9 million, compared to $78.1 million in 2024.
Outlook and guidance
On track for global regulatory submission, including IND for MGX-001 in 4Q 2026, with clinical trials expected to initiate in 2027 pending regulatory clearance.
Anticipates cash runway to support operations through the fourth quarter of 2027.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Metagenomi Therapeutics
- Advancing MGX-001 for hemophilia A with Q4 IND, strong preclinical data, and strategic focus.MGX
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Gene editing platform advances, with hemophilia A data and AI-driven enzyme discovery highlighted.MGXJefferies 2024 Global Healthcare Conference1 Feb 2026
- Durable, high-level Factor VIII expression and safety in NHPs support curative potential.MGXStudy Update22 Jan 2026
- Durable gene editing in Hem A and rapid pipeline progress highlight platform strength.MGX2024 Wells Fargo Healthcare Conference22 Jan 2026
- Hemophilia A gene editing program achieved 12-month preclinical durability, advancing toward IND.MGXH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Gene-editing platform shows durable results in hemophilia A and advances broad pipeline, partnerships.MGXChardan's 8th Annual Genetic Medicines Conference20 Jan 2026
- Gene-editing platform advances and strong preclinical data drive 2026 clinical plans.MGX43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026
- Durable gene editing for hemophilia A advances toward IND, with strong platform and partnerships.MGXTD Cowen 45th Annual Healthcare Conference26 Dec 2025
- Up to $250M in securities may be offered, with $75M via at-the-market sales through Jefferies.MGXRegistration Filing16 Dec 2025
Next Metagenomi Therapeutics earnings date
Q1 202612 May, 2026
Metagenomi Therapeutics
Next Metagenomi Therapeutics earnings date
Q1 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage